Abstract
Purpose. A series of 2-substituted-2-dimethylaminomethyl-5-(E)-arylidene cyclopentanones, 4 were synthesized. The main objective of this investigation was to explore the structural parameters necessary for antiinflammatory activity in this series of compounds, while keeping cytotoxic action to a minimum.
Methods. The target compounds were synthesized in two steps commencing with 2-alkyl-cyclopentanones. Antiinflammatory, analgesic and cytotoxic activities were determined in rats. Cytotoxic results were examined in human cell lines.
Results. Eight of the eighteen synthetic substances possessed significant antiinflammatory activity and twelve showed appreciable analgesic action. Cytotoxicity was minimal or non-existent for most of the compounds. The stability of one of the compounds, 4b in both aqueous and non-aqueous media, and an amine exchange reaction with aniline were used to explain the observed antiinflammatory and cytotoxic activities.
Conclusions. Unlike monosubstituted aminomethyl groups (Mannich bases) at the 2-position of 5-arylidene-2-cyclopentanones, a second substituent at the 2-position increases stability of the Mannich base and significantly decreases cytotoxic activity. Antiinflammatory and analgesic action is retained in many of the compounds, thus strongly indicating that these desired pharmacological results can be obtained without untoward damage to cells.
Similar content being viewed by others
REFERENCES
H. Chen, Y. Jing, Z. Ji, and B. Zhang. Acta Pharmaceutica Sinica. 26:183–192 (1991).
H. Chen, Z. Ji, L. Wong, J. F. Siuda, and V. L. Narayanan. Bioorgan. & Med. Chem. 2:1091–1097 (1994).
H. Wu, M. Ge, C. Yu, S. Li, and Y. Cheng. J. Bengbu Medical College. 16:234–237 (1991).
G. Elias, and M. N. A. Bao. Eur. J. Med. Chem. 23:379–380 (1988).
G. B. Singh, G. D. Leach and C. K. Atal. Arzneim-Forsch. 37:708–712 (1987).
G. B. Singh, G. D. Leach and C. K. Atal. Arznein-Forsch. 37:435–440 (1987).
E. E. Galantay. U.S. Patent. 4,273,787.
I. Katsumi, H. Kondo, K. Yamashita, K. Hosoe, T. Yamashita and K. Watanabe. Chem. Pharm. Bull. 34:121–124 (1986).
H. Shirota, K. Chiba, H. Ono, H. Yamamoto, S. Kobayashi, K. Terato, H. Ikuta, I. Yamatsu and K. Katayama. Arzneim-Forsch. 37:930–936 (1987).
Y. C. Martin. Quantitative Drug Design. Grunewald, G. L. ed. Marcel Dekker, Inc. New York, 1978, pp. 378–393.
A. Verloop, W. Hoogenstraaten and J. Tipker. Drug Design, Vol II., E. J. Ariens ed.; Academic Press, New York, 1976.
R. Mayer. Chem. Ber. 88:1853–1858 (1955).
A. Hassner and T. C. Mead. Tetrahedron Letters. 1223–1224 (1962).
C. A. Winter, E. A. Risley and G. A. Nuss. J. Pharmacology & Experimental Therapeutics 141:369–376 (1963).
E. Siegmund, R. Cadmus and G. Lu. Pro. Soc. Exp. Biol. Med. 95:729–731 (1959).
H. Chen, Z. Ji, L. Wong, J. F. Siuda and V. L. Narayanan. Drug Design and Discovery, in press.
M. R. Boyd. In Cancer: Principles and Practice of Oncology Update; Devita, V. T., Jr., Ed.; J. B. Lippincott: Philadelphia, 1989; 3(10), pp 1–12.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Chen, H., Ji, Z., Wong, L.K. et al. Synthesis, Antiinflammatory, and Cytotoxic Activities of 2-Alkyl and 2-Benzyl-2-Dimethylaminomethyl-5-(E)-Arylidene Cyclopentanone Hydrochlorides. Pharm Res 13, 1482–1487 (1996). https://doi.org/10.1023/A:1016067210281
Issue Date:
DOI: https://doi.org/10.1023/A:1016067210281